Clinical Study to Evaluate Effectiveness of Digital Refraction
NCT ID: NCT03502863
Last Updated: 2018-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2018-04-19
2018-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of a Hand-held Device Plus Mobile App Versus Standard Eye Care Devices in Measuring Refractive Error of the Eye
NCT03929588
Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction
NCT04693247
Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
NCT05049070
A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test
NCT06812572
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results
NCT01342393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
LogMAR (ETDRS) chart to measure visual acuity.
The manual manifest refraction is performed by an eyecare specialist using a phoropter.
The LogMAR Visual Acuity chart is used to measure visual acuity. The manual refraction will be used in this study for obtaining the refractive error of each eye.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digital refraction
Web-based application for obtaining the refractive error and visual acuity of each eye, using a computer and a smart phone
Manual Refraction
Manual refraction and ETDRS chart
Manual Refraction
Manual manifest refraction is performed by an eyesore specialist using a phoropter.
Digital refraction
A web-based application for obtaining the refractive error and visual acuity of each eye, using a computer and a smart phone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital refraction
A web-based application for obtaining the refractive error and visual acuity of each eye, using a computer and a smart phone.
Manual Refraction
Manual refraction and ETDRS chart
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject must have a refractive error
1. With no greater than -3.00 D myopia and -2.00 D astigmatism in either eye.
2. With prior correction of no greater than -10.00 D myopia and requiring over-refraction of no more than 2.75 D in either eye.
5\. Subjects with Best Corrected Visual Acuity (BCVA) of 20/32 or better.
Exclusion Criteria
2. Subjects using ophthalmic or systemic corticosteroids.
3. Subjects with autoimmune conditions.
4. Subjects with active corneal or conjunctival infection.
5. Subjects with active corneal, conjunctival, or intraocular inflammation (ie, uveitis).
6. Subjects with diabetic retinopathy.
7. Subjects with glaucoma or ocular hypertension.
8. Subjects with macular degeneration.
9. Subjects with previous ocular surgery.
10. Subjects on antihyperglycemic agents; corticosteroids; hydroxychloroquine (Plaquenil) and chloroquine (Aralen); tamoxifen (Nolvadex).
11. Pregnancy
12. Subjects who, in the judgment of the Investigator, may be inappropriate for the intended study procedures.
22 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Visibly
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S Lee
Role: STUDY_DIRECTOR
Sponsor GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 03
Fort Lauderdale, Florida, United States
Site 02
Nashville, Tennessee, United States
Site 01
Harlingen, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OPT-1001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.